Meredith S. Manning
Corporate Officer/Principal bei SOLENO THERAPEUTICS, INC.
Profil
Meredith S.
Manning is currently the Chief Commercial Officer at Soleno Therapeutics, Inc. She previously worked as the Vice President-Global Hemophilia Marketing at Baxter International, Inc. from 2013 to 2015.
She was also the President-Americas at PharmaEssentia Corp.
and the Chief Commercial Officer at resTORbio, Inc. from 2018 to 2019.
Ms. Manning received her undergraduate degree from The Colorado College and her MBA from The University of Chicago Booth School of Business.
Aktive Positionen von Meredith S. Manning
Unternehmen | Position | Beginn |
---|---|---|
SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 24.01.2024 |
Ehemalige bekannte Positionen von Meredith S. Manning
Unternehmen | Position | Ende |
---|---|---|
ADICET BIO, INC. | Corporate Officer/Principal | 06.12.2019 |
BAXTER INTERNATIONAL INC. | Sales & Marketing | 01.07.2015 |
PHARMAESSENTIA CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Meredith S. Manning
The Colorado College | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
SOLENO THERAPEUTICS, INC. | Health Technology |
PHARMAESSENTIA CORPORATION | Health Technology |
Private Unternehmen | 1 |
---|---|
resTORbio, Inc.
resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |